Integer Holdings Corporation Announces Preliminary Unaudited Sales Results and Acquisition of Pulse Technologies
10 janv. 2024 16h15 HE
|
Integer Holdings Corporation
~ Preliminary unaudited full year 2023 sales increase 16% versus 2022 ~~ Acquisition adds highly differentiated micro machining capability in high growth end markets ~~ Schedules conference call for...
Integer to Participate in 42nd Annual J.P. Morgan Healthcare Conference
03 janv. 2024 08h00 HE
|
Integer Holdings Corporation
PLANO, Texas, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE:ITGR) today announced participation in the upcoming 42nd Annual J.P. Morgan Healthcare Conference to be held in San...
Esperion Provides Preliminary Fourth Quarter 2021 Financial Results and CLEAR Outcomes Program Update
11 janv. 2022 08h00 HE
|
Esperion Therapeutics, Inc.
– Unprecedented CLEAR Outcomes Trial Remains On-Track for Complete Major Adverse Cardiac Events (MACE) Accumulation in 2H 2022; Achieved 85% MACE Accumulation in December – – Fourth-quarter 2021 U.S....
Caribou Biosciences to Present at 40th Annual J.P. Morgan Healthcare Conference
04 janv. 2022 16h05 HE
|
Caribou Biosciences, Inc.
BERKELEY, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Caribou Biosciences, Inc. (Nasdaq:CRBU), a leading clinical-stage CRISPR genome-editing biopharmaceutical company, announced today that Rachel...
Esperion to Present at the 39th Annual J.P. Morgan Healthcare Conference
21 déc. 2020 08h00 HE
|
Esperion Therapeutics, Inc.
ANN ARBOR, Mich., Dec. 21, 2020 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR), today announced that President and Chief Executive Officer, Tim M. Mayleben, will present at the virtual 39th Annual J.P....
Clearside Biomedical to Present at the 38th Annual J.P. Morgan Healthcare Conference
06 janv. 2020 07h05 HE
|
Clearside Biomedical, Inc.
ALPHARETTA, Ga., Jan. 06, 2020 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company dedicated to developing and delivering treatments that restore and preserve...
Esperion to Participate in Fireside Chat at the 36th Annual J.P. Morgan Healthcare Conference
03 janv. 2018 16h30 HE
|
Esperion Therapeutics, Inc.
Fireside Chat Webcast on Wednesday, January 10, 2018 at 11:00 a.m. Pacific Time / 2:00 p.m. Eastern Time ANN ARBOR, Mich., Jan. 03, 2018 (GLOBE NEWSWIRE) -- Esperion Therapeutics, Inc....